Bausch Health Companies Inc
(BHC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -209,000 | -212,000 | 198,000 | -205,000 | -66,000 |
| Depreciation Amortization | 330,000 | 1,493,000 | 1,120,000 | 763,000 | 366,000 |
| Income taxes - deferred | N/A | -176,000 | -195,000 | -99,000 | -83,000 |
| Accounts receivable | 108,000 | -57,000 | -26,000 | 107,000 | 197,000 |
| Accounts payable and accrued liabilities | -8,000 | -75,000 | -122,000 | -26,000 | -75,000 |
| Other Working Capital | -61,000 | -396,000 | -374,000 | -105,000 | 16,000 |
| Other Operating Activity | -6,000 | -1,305,000 | -1,804,000 | -375,000 | -418,000 |
| Operating Cash Flow | $154,000 | $-728,000 | $-1,203,000 | $60,000 | $-63,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -47,000 | -218,000 | -152,000 | -98,000 | -46,000 |
| Net Acquisitions | N/A | -40,000 | N/A | N/A | N/A |
| Purchase Of Investment | -44,000 | -17,000 | -15,000 | -14,000 | -5,000 |
| Sale Of Investment | 11,000 | 22,000 | 20,000 | 13,000 | 6,000 |
| Purchase Sale Intangibles | -4,000 | -50,000 | -20,000 | -15,000 | -11,000 |
| Other Investing Activity | 2,000 | -50,000 | -20,000 | -15,000 | -11,000 |
| Investing Cash Flow | $-78,000 | $-303,000 | $-167,000 | $-114,000 | $-56,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 155,000 | 6,836,000 | 6,481,000 | 6,320,000 | 986,000 |
| Debt Repayment | -279,000 | -7,846,000 | -7,224,000 | -7,083,000 | -485,000 |
| Common Stock Issued | N/A | 675,000 | 675,000 | 675,000 | N/A |
| Other Financing Activity | -18,000 | -139,000 | -130,000 | -74,000 | -33,000 |
| Financing Cash Flow | $-142,000 | $-474,000 | $-198,000 | $-162,000 | $468,000 |
| Exchange Rate Effect | 6,000 | -23,000 | -54,000 | -24,000 | -8,000 |
| Beginning Cash Position | 591,000 | 2,119,000 | 2,119,000 | 2,119,000 | 2,119,000 |
| End Cash Position | 531,000 | 591,000 | 497,000 | 1,879,000 | 2,460,000 |
| Net Cash Flow | $-60,000 | $-1,528,000 | $-1,622,000 | $-240,000 | $341,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 154,000 | -728,000 | -1,203,000 | 60,000 | -63,000 |
| Capital Expenditure | -47,000 | -218,000 | -152,000 | -98,000 | -46,000 |
| Free Cash Flow | 107,000 | -946,000 | -1,355,000 | -38,000 | -109,000 |